CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
CDAK
Delisted
CDAK was delisted on the 4th of April, 2023.
62 hedge funds and large institutions have $86.5M invested in Codiak BioSciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $211K
Holders
62
Holding in Top 10
1
Calls
$1K
Puts
$211K
Top Buyers
| 1 | +$997K | |
| 2 | +$635K | |
| 3 | +$401K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$267K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$257K |
Top Sellers
| 1 | -$969K | |
| 2 | -$422K | |
| 3 | -$91.7K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$71.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$41K |